Article 37(4) of Regulation (EU) 2019/6 requires the Commission to adopt delegated acts establishing criteria that will allow the Commission to determine which antimicrobials or groups of antimicrobials should be reserved for human use.
Recital 3, Regulation (EU) 2021/1760
In forcesince 26 May 2021